ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 755264 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 755264; 2) Community: the network communities that were significantly associated with the response to NSC 755264; 3) Molecule: the relationships between components within communities and NSC 755264; 4) MDR: the compounds that were significantly associated with the NSC 755264.

NSC Compound Enrichment Correlation
NSC 727087 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.00415749398947839 0.25818819
NSC 740 Methotrexate 0.00415749398947839 0.43734254
NSC 746540 Null 0.00415749398947839 0.20382977
NSC 748715 Null 0.00415749398947839 -0.081968725
NSC 754245 5-(2-(dimethylamino)ethyl)-2,8-dimethoxy-5H-indeno[1,2-c]quinoline-6,11-dione 0.00415749398947839 0.50381106
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.00415749398947839 0.21500835
NSC 114346 Null 0.0041872854493286 0.28182552
NSC 126228 Ethanesulfonic acid, compd. with m-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) 0.0041872854493286 0.36773183
NSC 244404 Null 0.0041872854493286 0.39309349
NSC 303812 Aphidicoline glycinate 0.0041872854493286 0.44312119
Total:158  Current:21    [First] [Prev] [Next] [Last]